UCV 100
Alternative Names: UC-100; UCV-100; Vacino-CLatest Information Update: 15 Dec 2022
At a glance
- Originator Vacino Biotech
- Class COVID-19 vaccines; Peptide vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections
Most Recent Events
- 15 Dec 2022 Preclinical trials in COVID-2019 infections in China (Parenteral) before December 2022 (Vacino Biotech pipeline, December 2022)